Clinical Trials List
2022-07-01 - 2028-12-31
Phase II
Recruiting5
ICD-10C53.9
Malignant neoplasm of cervix uteri, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9180.9
Malignant neoplasm of cervix uteri, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
- Shao-Jung Hsu Digestive System Department
- 林泰祺 Division of Ophthalmology
- Yi-Ping Hung Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
- Jiun-I Lai Division of Hematology & Oncology
- Hao-Wei Teng Division of Hematology & Oncology
- Yun-Cheng Hsieh Digestive System Department
- San-Chi Chen Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- Chueh-Chuan Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsai-Sheng Yang Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Ting-Chang Chang Division of Obstetrics & Gynecology
- Yun-Hsin Tang Division of Obstetrics & Gynecology
- Angel Chao Division of Obstetrics & Gynecology
- Wen-Chi Shen Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Gigin Lin Division of Radiology
- 陳宏吉 Division of Ophthalmology
- 黃寬仁 Division of Obstetrics & Gynecology
- Chyong-Huey Lai Division of Obstetrics & Gynecology
- Yung-Chang Lin Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Cheng-Tao Lin Division of Obstetrics & Gynecology
- Min-Yu Chen Division of Obstetrics & Gynecology
- HSIU-JUNG TUNG Division of Obstetrics & Gynecology
- Wen-Chi Chou Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- 周宏學 Division of Obstetrics & Gynecology
- 陳威君 Division of Obstetrics & Gynecology
- Huei-Jean Huang Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kun-Huei Yeh Division of Hematology & Oncology
- FU-JEN HSUEH Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 吳宗哲 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Yu-Chieh Tsai Division of Hematology & Oncology
- Wen-Fang Cheng Division of Obstetrics & Gynecology
- 陳國興 Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Hsin-Yu Liu Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃文聰 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
58 participants
-
Global
575 participants
